HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Previous close
$3.51
Day range
$3.34 - $3.55
Year range
$1.30 - $5.22
Market cap
2.46B USD
Avg Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.21M | 176.50% |
Net income | -36.57M | -90.17% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -36.18M | -182.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 186.24M | -46.58% |
Total assets | 202.95M | -69.44% |
Total liabilities | 125.26M | -76.70% |
Total equity | 77.69M | — |
Shares outstanding | 701.70M | — |
Price to book | 31.91 | — |
Return on assets | -42.96% | — |
Return on capital | -46.44% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | -36.57M | -90.17% |
Cash from operations | -19.46M | -474.86% |
Cash from investing | 60.57M | 605,580.00% |
Cash from financing | 6.25M | -98.80% |
Net change in cash | 47.63M | -90.96% |
Free cash flow | -480.93M | -61.57% |
About
Founded
2003
Website
Employees
105
